246 related articles for article (PubMed ID: 24059685)
1. The role of hepatocyte nuclear factor 4alpha in metastatic tumor formation of hepatocellular carcinoma and its close relationship with the mesenchymal-epithelial transition markers.
Yao D; Peng S; Dai C
BMC Cancer; 2013 Sep; 13():432. PubMed ID: 24059685
[TBL] [Abstract][Full Text] [Related]
2. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
3. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA.
Wang SC; Lin XL; Li J; Zhang TT; Wang HY; Shi JW; Yang S; Zhao WT; Xie RY; Wei F; Qin YJ; Chen L; Yang J; Yao KT; Xiao D
PLoS One; 2014; 9(7):e101330. PubMed ID: 24992599
[TBL] [Abstract][Full Text] [Related]
5. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
Tanaka S; Shiraha H; Nakanishi Y; Nishina S; Matsubara M; Horiguchi S; Takaoka N; Iwamuro M; Kataoka J; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Nouso K; Yagi T; Yamamoto K
Int J Cancer; 2012 Dec; 131(11):2537-46. PubMed ID: 22488108
[TBL] [Abstract][Full Text] [Related]
6. 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.
Liu TA; Jan YJ; Ko BS; Liang SM; Chen SC; Wang J; Hsu C; Wu YM; Liou JY
PLoS One; 2013; 8(3):e57968. PubMed ID: 23483955
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.
Yang MH; Chen CL; Chau GY; Chiou SH; Su CW; Chou TY; Peng WL; Wu JC
Hepatology; 2009 Nov; 50(5):1464-74. PubMed ID: 19821482
[TBL] [Abstract][Full Text] [Related]
8. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
Song FN; Duan M; Liu LZ; Wang ZC; Shi JY; Yang LX; Zhou J; Fan J; Gao Q; Wang XY
PLoS One; 2014; 9(9):e108507. PubMed ID: 25268581
[TBL] [Abstract][Full Text] [Related]
9. Tg737 regulates epithelial-mesenchymal transition and cancer stem cell properties via a negative feedback circuit between Snail and HNF4α during liver stem cell malignant transformation.
Huang Q; Pu M; Zhao G; Dai B; Bian Z; Tang H; Chen C; Liu W; Qu X; Shen L; Tao K
Cancer Lett; 2017 Aug; 402():52-60. PubMed ID: 28536011
[TBL] [Abstract][Full Text] [Related]
10. A double-negative feedback loop between Wnt-β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinoma.
Yang M; Li SN; Anjum KM; Gui LX; Zhu SS; Liu J; Chen JK; Liu QF; Ye GD; Wang WJ; Wu JF; Cai WY; Sun GB; Liu YJ; Liu RF; Zhang ZM; Li BA
J Cell Sci; 2013 Dec; 126(Pt 24):5692-703. PubMed ID: 24101726
[TBL] [Abstract][Full Text] [Related]
11. Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells.
Karaosmanoğlu O; Banerjee S; Sivas H
Cell Oncol (Dordr); 2018 Aug; 41(4):439-453. PubMed ID: 29858962
[TBL] [Abstract][Full Text] [Related]
12. The stable repression of mesenchymal program is required for hepatocyte identity: a novel role for hepatocyte nuclear factor 4α.
Santangelo L; Marchetti A; Cicchini C; Conigliaro A; Conti B; Mancone C; Bonzo JA; Gonzalez FJ; Alonzi T; Amicone L; Tripodi M
Hepatology; 2011 Jun; 53(6):2063-74. PubMed ID: 21384409
[TBL] [Abstract][Full Text] [Related]
13. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
Zhou W; Gong L; Wu Q; Xing C; Wei B; Chen T; Zhou Y; Yin S; Jiang B; Xie H; Zhou L; Zheng S
J Exp Clin Cancer Res; 2018 Sep; 37(1):215. PubMed ID: 30180906
[TBL] [Abstract][Full Text] [Related]
14. Abrogating K458 acetylation enhances hepatocyte nuclear factor 4α (HNF4α)-induced differentiation therapy for hepatocellular carcinoma.
Liu F; Peng Y; Qian H; Xiao MC; Ding CH; Zhang X; Xie WF
J Dig Dis; 2024 Apr; 25(4):255-265. PubMed ID: 38837552
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met/Snail signaling.
Zhang JP; Zeng C; Xu L; Gong J; Fang JH; Zhuang SM
Oncogene; 2014 Jul; 33(31):4069-76. PubMed ID: 24013226
[TBL] [Abstract][Full Text] [Related]
16. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.
Zhu K; Dai Z; Pan Q; Wang Z; Yang GH; Yu L; Ding ZB; Shi GM; Ke AW; Yang XR; Tao ZH; Zhao YM; Qin Y; Zeng HY; Tang ZY; Fan J; Zhou J
Clin Cancer Res; 2011 Dec; 17(23):7294-302. PubMed ID: 21976539
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma.
Yao HS; Wang J; Zhang XP; Wang LZ; Wang Y; Li XX; Jin KZ; Hu ZQ; Wang WJ
Mol Carcinog; 2016 May; 55(5):458-72. PubMed ID: 25808746
[TBL] [Abstract][Full Text] [Related]
18. FOXF2 deficiency promotes hepatocellular carcinoma metastasis by inducing mesenchymal-epithelial transition.
Dou C; Jin X; Sun L; Zhang B; Han M; Li T
Cancer Biomark; 2017 Jul; 19(4):447-454. PubMed ID: 28582850
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional repressor snail and metastasis in hepatocellular carcinoma.
Chen D; Zheng X; Jiao X; Gao Y; Zhang K; Liang J
Hepatogastroenterology; 2012; 59(117):1359-65. PubMed ID: 22107747
[TBL] [Abstract][Full Text] [Related]
20. miR-153 inhibits epithelial-to-mesenchymal transition in hepatocellular carcinoma by targeting Snail.
Xia W; Ma X; Li X; Dong H; Yi J; Zeng W; Yang Z
Oncol Rep; 2015 Aug; 34(2):655-62. PubMed ID: 26035427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]